1. Home
  2. CASI vs HKIT Comparison

CASI vs HKIT Comparison

Compare CASI & HKIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CASI
  • HKIT
  • Stock Information
  • Founded
  • CASI 1991
  • HKIT 1996
  • Country
  • CASI China
  • HKIT China
  • Employees
  • CASI N/A
  • HKIT N/A
  • Industry
  • CASI Biotechnology: Pharmaceutical Preparations
  • HKIT Computer Software: Prepackaged Software
  • Sector
  • CASI Health Care
  • HKIT Technology
  • Exchange
  • CASI Nasdaq
  • HKIT Nasdaq
  • Market Cap
  • CASI 35.8M
  • HKIT 39.8M
  • IPO Year
  • CASI 1996
  • HKIT 2023
  • Fundamental
  • Price
  • CASI $2.28
  • HKIT $1.75
  • Analyst Decision
  • CASI Strong Buy
  • HKIT
  • Analyst Count
  • CASI 1
  • HKIT 0
  • Target Price
  • CASI $4.00
  • HKIT N/A
  • AVG Volume (30 Days)
  • CASI 384.8K
  • HKIT 42.8K
  • Earning Date
  • CASI 11-13-2025
  • HKIT 10-27-2025
  • Dividend Yield
  • CASI N/A
  • HKIT N/A
  • EPS Growth
  • CASI N/A
  • HKIT N/A
  • EPS
  • CASI N/A
  • HKIT N/A
  • Revenue
  • CASI $31,564,000.00
  • HKIT $2,904,950.00
  • Revenue This Year
  • CASI N/A
  • HKIT N/A
  • Revenue Next Year
  • CASI N/A
  • HKIT N/A
  • P/E Ratio
  • CASI N/A
  • HKIT N/A
  • Revenue Growth
  • CASI 36.64
  • HKIT N/A
  • 52 Week Low
  • CASI $1.09
  • HKIT $1.15
  • 52 Week High
  • CASI $7.55
  • HKIT $2.08
  • Technical
  • Relative Strength Index (RSI)
  • CASI 55.66
  • HKIT 61.37
  • Support Level
  • CASI $2.18
  • HKIT $1.48
  • Resistance Level
  • CASI $2.49
  • HKIT $2.08
  • Average True Range (ATR)
  • CASI 0.19
  • HKIT 0.10
  • MACD
  • CASI -0.03
  • HKIT 0.04
  • Stochastic Oscillator
  • CASI 33.33
  • HKIT 46.00

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

About HKIT Hitek Global Inc.

Hitek Global Inc is a provider of information technology consulting and solutions services. The company has two lines of businesses such as services to small and medium businesses, which consist of Anti-Counterfeiting Tax Control System tax devices, including Golden Tax Disk and printers, ACTCS services, and IT services; and services to large businesses, which include hardware sales and software sales. It generates revenues from hardware sales, software sales, IT services, and tax devices and services.

Share on Social Networks: